Table 9 Effect of NAR and NAR-HNPs on hippocampal monoamines and metabolites in experimental rats.
Groups | Parameters | ||||
|---|---|---|---|---|---|
Hippocampus (μg/g) | |||||
NE | 5-HT | 5-HTAA | DA | DOPAC | |
Normal | 0.62b ± 0.02 | 0.62b ± 0.05 | 0.13b ± 0.01 | 1.50b ± 0.05 | 0.26b ± 0.02 |
Free NAR | 0.60b ± 0.01 | 0.62b ± 0.06 | 0.15b ± 0.01 | 1.35b ± 0.02 | 0.25b ± 0.00 |
NAR-HNPs | 0.57b ± 0.02 | 0.71b ± 0.07 | 0.14b ± 0.00 | 1.53b ± 0.07 | 0.26b ± 0.02 |
Control STZ | 0.43acd ± 0.02 | 0.36 acd ± 0.01 | 0.20 acd ± 0.00 | 1.00 acd ± 0.07 | 0.35 acd ± 0.01 |
STZ + unloaded HNPs | 0.40 acd ± 0.02 | 0.40 acd ± 0.03 | 0.19 acd ± 0.01 | 1.09 acd ± 0.01 | 0.34 acd ± 0.00 |
STZ + NAR (50 mg/kg) | 0.53abd ± 0.00 | 0.54 bd ± 0.01 | 0.17 abd ± 0.01 | 1.32 abd ± 0.05 | 0.27bd ± 0.02 |
STZ + NAR-HNPs (50 mg/kg) | 0.62bc ± 0.01 | 0.70 bc ± 0.02 | 0.14bc ± 0.01 | 1.70abc ± 0.10 | 0.23 bc ± 0.01 |
STZ + NAR (50 mg/kg) + GW9662 | 0.43 acd ± 0.01 | 0.39 acd ± 0.01 | 0.20 acd ± 0.01 | 1.04 acd ± 0.08 | 0.34 acd ± 0.01 |